ABILIFY BIIAMPA Trademark

Trademark Overview

On Wednesday, February 17, 2021, a trademark application was filed for ABILIFY BIIAMPA with the United States Patent and Trademark Office. The USPTO has given the ABILIFY BIIAMPA trademark a serial number of 79308682. The federal status of this trademark filing is REGISTERED as of Tuesday, March 29, 2022. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The ABILIFY BIIAMPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders
abilify biiampa

General Information

Serial Number79308682
Word MarkABILIFY BIIAMPA
Filing DateWednesday, February 17, 2021
Status700 - REGISTERED
Status DateTuesday, March 29, 2022
Registration Number6681576
Registration DateTuesday, March 29, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Sunday, March 12, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, September 12, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, August 23, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, August 23, 2022FINAL DISPOSITION PROCESSED
Wednesday, June 29, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 29, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Monday, January 10, 2022NOTIFICATION PROCESSED BY IB
Wednesday, December 22, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 22, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 5, 2021REFUSAL PROCESSED BY IB
Monday, June 14, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 14, 2021REFUSAL PROCESSED BY MPU
Thursday, June 10, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 9, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 2, 2021ASSIGNED TO EXAMINER
Tuesday, May 11, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, May 11, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, April 24, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, April 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 19, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 15, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

biiampa abilify system diseases disorders nervous central preparations treatment pharmaceutical